rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ALC
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Stifel cuts Alcon stock price target on 2027 growth concerns
      Nov 12Investing.comALC
      Bernstein cuts Alcon stock price target on Q3 revenue miss
      Nov 12Investing.comALC
      Jefferies reiterates Alcon stock Buy rating, lowers estimates
      Nov 12Investing.comALC
      What Could Alcon (SWX:ALC) Q3 Sales And New Deal Mean For Growth?

      Alcon (SWX:ALC) reported strong Q3 2026 sales performance, underscoring momentum in its core eye care operations. The firm received US FDA approvals for new intraocular lens products intended for use in cataract and vision correction procedures. Management broadened the portfolio with the acquisition of Neurotech Pharmaceuticals, adding drug delivery capabilities in ophthalmology. The Q3 sales update and Neurotech Pharmaceuticals deal matter. However, investors should weigh more than this...

      Nov 12Yahoo FinanceALC
      Alcon: 3 Key Takeaways for Long-Term Investors
      Nov 11Yahoo FinanceALC
      Alcon Inc. (ALC) Q3 2026 Earnings Call Transcript

      Detailed price information for Unity Software Inc (U-N) from The Globe and Mail including charting and trades.

      Nov 11The Globe and MailALC
      Alcon Inc (ALC) (Q3 2026) Earnings Call Highlights: Solid Sales Growth and Margin Expansion ...
      Nov 11Yahoo FinanceALC
      Alcon Stocks Fall 4% After Lens Implant Sales Slip and Guidance Narrows
      Nov 11Yahoo FinanceALC
      Implantable Headwinds Clip Alcon Revenue Pace Despite Solid Premium Lens Gains
      Nov 11BenzingaALC
      Alcon Q3 2026 presentation: EPS beats forecast, shares fall on revenue
      Nov 11Investing.comALC
      Alcon Q3 2026 Earnings Call Transcript
      Nov 11BenzingaALC
      Alcon Inc. Q3 2026 Earnings Call Summary
      Nov 11Yahoo FinanceALC
      Why is Alcon stock sliding today?
      Nov 11Investing.comALC
      Alcon shares drop 5% despite earnings beat on tighter outlook
      Nov 11Investing.comALC
      Alcon shares fall as tighter eye-care market outlook raises growth concerns
      Nov 11ReutersALC
      Alcon (ALC) Reports Q3 Earnings: What Key Metrics Have to Say
      Nov 10Yahoo FinanceALC
      Alcon earnings up next: Can product launches sustain momentum?
      Nov 10Investing.comALC
      Countdown to Alcon (ALC) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
      Nov 5Yahoo FinanceALC
      Alcon (ALC) Surges 6.8%: Is This an Indication of Further Gains?
      Nov 5Yahoo FinanceALC
      Alcon Inc. (ALC) Is Positioned to Benefit From Long-Term Healthcare Demand: Here’s the Investment Case
      Nov 4Yahoo FinanceALC
      Needham reiterates Alcon stock rating on Neurotech acquisition
      Nov 2Investing.comALC
      Alcon (SWX:ALC) The Latest Update Raises A Bigger Question
      Oct 30Yahoo FinanceALC
      Alcon: Keeping An Eye Out Here Amid Sales And Margin Momentum (NYSE:ALC)
      Oct 26Seeking AlphaALC
      Alcon's Neurotech Acquisition Offers Significant Growth Potential, Needham Says
      Oct 21Yahoo FinanceALC
      Alcon Sees Another Bullish Rating After Clear Portfolio Growth Direction In Eyecare (ALC)

      Alcon Inc. remains a Buy, supported by FDA approvals, portfolio-expanding acquisitions, and robust long-term eyecare demand. Click for more details on ALC.

      Oct 21Seeking AlphaALC
      Alcon Acquires Neurotech for $550 Million
      Oct 20Yahoo FinanceALC
      Alcon Wins FDA Approval for Brytly Redness Reliever Eye Drops
      Oct 16Yahoo FinanceALC
      FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes

      Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that the U.S. Food and Drug Administration has approved BRYTLY ® Redness Reliever Eye Drops. With one drop, BRYTLY works in just one minute to significantly reduce redness and delivers up to 12 hours of whiter, brighter-looking eyes. 1 Additionally, BRYTLY lasts up...

      Oct 16NasdaqALC
      Alcon Gets FDA Approval for Brytly Eye Drops
      Oct 16MorningstarALC
      Lifecore Extends Manufacturing Contract With Alcon Research
      Sep 29Yahoo FinanceLFCRALC
      Introducing Systane® PRO PRESERVATIVE-FREE: Alcon’s Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief
      Sep 28MorningstarALC
      Alcon (SWX:ALC) Stock Trades Above Fair Value On Earnings Pressure

      Alcon has seen its share price grind lower in recent years, which naturally puts a spotlight on whether the current valuation still lines up with what the business earns. For anyone tracking the stock, the core question is whether the recent price level reflects a fair read of Alcon's earnings power. The share price has declined 26.8% over the past 5 years, which puts real pressure on the idea that the current market value is in step with the earnings the company produces. The business model...

      Sep 27Yahoo FinanceALC
      Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO) and Alcon (ALC)

      Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

      Sep 24The Globe and MailALC
      Analysts Are Bullish on Top Healthcare Stocks: Alcon (ALC), Intuitive Surgical (ISRG)

      Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

      Sep 22The Globe and MailALC
      Alcon CEO Says US Drug Pricing Deal May Limit European Products
      Sep 14BloombergALC
      Mason Cisney Alcon Wealth Management Group Joins UBS in Pueblo, CO

      PUEBLO, Colo., September 04, 2026--UBS today announced that Financial Advisors Caitlin Alcon, Calvin Mason, and Craig Cisney will be joining the firm. They will be joining the UBS Mountain West Market, managed by Mitch Markley, and will report to Market Director Justin French.

      Sep 4Yahoo FinanceALCUBS
      Alcon: A Re-Rating In Eyesight
      Sep 3Seeking AlphaALC
      Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
      Sep 3MorningstarALC
      Are Options Traders Betting on a Big Move in Alcon Stock?
      Sep 3Yahoo FinanceALC
      Alcon (SWX:ALC), What Is Behind The Fresh Attention?

      Alcon stock reacts to US Medicaid drug pricing agreement New US Medicaid drug pricing agreements involving Alcon (SWX:ALC) and eight other healthcare companies have put the stock in focus for investors assessing potential implications for its eye care drug portfolio. At around CHF58.30 per share, Alcon has seen short term share price pressure related to the Medicaid headlines, with the 1-day share price return down 0.44% and the year-to-date share price return down 8.25%. In contrast, the...

      Sep 2Yahoo FinanceALC
      Alcon's Clareon Monofocal IOL Receives EUMDR Certification Through TÜV SÜD

      Alcon, a global leader in eye care, announced that TÜV SÜD has certified the Clareon® Monofocal intraocular lens (IOL) for MDR compliance. This certification is supported by clinical evidence, including more than 30 peer-reviewed publications demonstrating the Clareon® Monofocal IOL's ability to deliver sharp, clear distance vision along with functional intermediate visual acuity.1 Alcon is currently updating the Clareon Monofocal IFU to reflect the extended claim for depth of focus for intermed

      Sep 1Yahoo FinanceALC
      Alcon prices €500 million senior notes due 2033
      Aug 26Investing.comALC
      Alcon Prices EUR 500 Million Senior Notes Offering

      GENEVA, August 26, 2026--Alcon Prices EUR 500 Million Senior Notes Offering

      Aug 26Yahoo FinanceALC
      Alcon Prices Senior Notes due 2033

      Alcon (ALC) said late Wednesday it priced a public offering of 500 million euros ($582.6 million) of

      Aug 26Yahoo FinanceALC
      SGA Exits Alcon (ALC) as Cataract Demand Slows and Competition Rises

      Sustainable Growth Advisers (SGA), an investment management company, released its second-quarter 2026 investor letter for its “Global Growth Strategy.” The letter can be downloaded here. The SGA Global Growth Portfolio returned 7.4% gross and 7.2% net, compared with 14.9% for the MSCI ACWI and 19.8% for the MSCI ACWI Growth Index. Momentum leadership and enthusiasm around […]

      Aug 24Yahoo FinanceALC

      This is the newest page. Registered accounts read further back.